CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Peter M. Fischer

OPENALEX: A5041852883↗ORCID: 0000-0002-5866-9271↗

Affiliations

Organizations

University of Nottinghamauthorship · GB

Public evidence

1 connected articles

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.2017 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Peter M. Fischer - Medical Cannabis Research Engine